Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: sulfa (sulfonamide antibiotics) / augmentin / trimethoprim / macrolide antibiotics attending: chief complaint: nausea/vomiting major surgical or invasive procedure: none history of present illness: 58 yo f with recurrent stage iiia nsclc s/p carboplatin and pemetrexed on and recent admission here for gastroparesis who presented 2 days after discharge from here to with similar symptoms. there she was treated symptomatically. cardiac biomarkers were checked and noted to be elevated, with a trop t of 4.9, ck normal, ekg normal. cards was consulted, and she underwent a stress test that was negative. she was treated with 48 hours of heparin. per nursing report, stopped heparin 'dropping counts' and concern for hit. no hit antibody testing in discharge paperwork. gi was also consulted and recommended symptomatic treatment with no egd necessary, given recent egd. she was transferred here for further management and concern for possible brain metastases given intractable n/v. of note, she had an mri in for same concern, which was negative for metastases. . she triggered on arrival to the floor here at for htn to 200/100 hr 110. ekg unchanged. htn likely related to n/v/abdominal pain. . she reported mild epigastric pain. she was diagnosed with gastroparesis in based on a gastric empyting study after presenting n/v. she states that she rarely eats because she's afraid to. she's lost ~ 20lbs. she denies constipation or diarrhea. . ros: denies cp, sob, palpitations, cough, ha, change in vision, dysuria, myalgias or arthralgias. she endorses depressed mood. . past medical history: locoregional recurrent nsclc -- presented with several months of persistent cough unresponsive to antibiotics. -- chest x-ray demonstrated a density in the left mid lung, which was confirmed by a chest ct. -- chest ct revealing a 1.8-cm left upper lobe spiculated mass with pleural extension consistent with a malignant neoplasm. she also had a 2.6-cm right adrenal mass thought to be a simple adenoma as well as a 2.1-cm left lobe focus of nodular hyperplasia in the liver confirmed on an mri. -- staging with pet ct showing increased activity in the left upper lobe nodule. brain mri at the time of diagnosis was negative. -- , she underwent a left upper lobectomy and mediastinal lymph node dissection with pathology revealing adenocarcinoma with bronchioalveolar features well-to-moderately differentiated in a 1.5 cm tumor. she had lymphovascular invasion and one of three peribronchial lymph nodes was positive. there was also a tumor in the periaortic lymph node in the ap window region giving her a t1 n2 stage iiia nonsmall cell lung cancer adenocarcinoma. -- she was treated postoperatively with one cycle of paclitaxel and carboplatin, but was hospitalized post infusion on with chest pain, which was a st elevation mi. she underwent emergent catheterization with a 60% lad stenosis for which she got a cypher drug-eluting stent. she did not receive further paclitaxel chemotherapy, but was started on a regimen of cisplatin and vinorelbine, which she received a single cycle on , which was complicated by a mrsa uti as well as a decrement in her creatinine clearance to 57 ml/min down from over 100. -- she subsequently declined any further chemotherapy and did not receive radiotherapy either. -- she did not continue to follow with her oncologist, but got periodic ct scans via her surgeon and pcp. ct with no evidence of recurrence, although a small nodule is noted in the left lower lobe measuring 3 mm, which had not been reliably demonstrated on the prior study. no mediastinal adenopathy reported on the scan. -- came to ed with epigastric pain, emesis, and dizziness. she underwent an egd with gastritis and gastric emptying study consistent with gastroparesis. -- ct which confirmed a new soft tissue abnormality in the left mediastinum starting just distal to the aortic arch associated with abnormal density surrounding the left main bronchus posteriorly and small lymph nodes in the left hilum suspicious for lung cancer recurrence. she also had a small pericardial effusion, a 2-mm right upper lobe nodule with associated ground-glass opacity. again, seen was a 2.5-cm adrenal lesion and a right hepatic lobe lesion. she also underwent on an mri of her l-spine, which was stopped for pain, but did not show metastatic involvement. anti- antibodies were negative. -- , she underwent a bronchoscopy with ebus, which showed a station 4l lymph node positive for malignant cells consistent with nonsmall cell cancer. the left main stem bronchus biopsy was only notable for bronchial mucosa and a level 7 node was negative. -- pet ct on , which confirmed a pet avid paratracheal soft tissue density with an suv of 6.7; a left hilar mass along the left main stem bronchus, which was also pet avid at suv of 4.9; and a non pet-avid 6-mm right hilar lymph node; and 3-mm right lower lobe subpleural nodule. there was no fdg avidity seen outside of the chest and her adrenal mass is non pet-avid. -- mri brain: subtle enhancement in the left parietal leptomeningeal area felt to represent a tiny vascular lesion like a cavernoma. there is also question of an enhancing lesion in the left cerebellum but without associated mass effect or edema. -- chest ct with slight interval increase in adenopathy, no new findings. -- c1 of carboplatin/pemetrexed -- radiation therapy at hospital . . other medical history: cad s/p stemi during paclitaxel, s/p cypher drug-eluting stent to the lad on fibromyalgia history of pneumonia uterine fibroids status post fibroidectomy copd incisional hernia adrenal adenoma status post appendectomy in neuropathy along the thoracotomy site history of mvc with head trauma requiring multiple sutures, no reported intracranial pathology social history: she lives alone. she is a current smoker (a pack per week, down from a pack/day). she does not drink. family history: her father had bladder cancer. physical exam: discharge vs: 98 220/120 110 22 93% ra gen: chronically ill appearing f in nad heent: dry mmm, pale conjunctiva, perrl neck: supple cv: tachy, regular no mrg lungs: ctab abd: hyperactive bs, soft, mild ttp epigastrically, none elsewhere, slight voluntary guarding over epigastric area neuro: no focal deficits psych: appropriate mood and affect admission vs: 97.5 108/68 (sbp 102-140) 92 (83-96) 16 97%ra gen: nad, aox3, pleasant heent: perrl, op clear, mmm, neck: supple, no lad cv: rrr, no m/r/g lungs: cta b/l, no rhonchi/wheezes/rales abd: soft, nt/nd +bs skin: no rashes, ulcers, lesions noted neuro: cnii-xii wnl, motor upper extremity , lower extremity . gait not observed pertinent results: counts 03:30am wbc-5.1 rbc-3.84* hgb-10.8* hct-31.4* mcv-82 mch-28.1 mchc-34.4 rdw-16.2* plt ct-231 05:30am wbc-9.5 rbc-4.10* hgb-11.5* hct-34.8* mcv-85 mch-28.1 mchc-33.1 rdw-15.9* plt ct-271 coags 05:05am pt-12.8 ptt-28.5 inr(pt)-1.1 chemistry 03:30am glucose-89 urean-5* creat-0.6 na-139 k-4.0 cl-105 hco3-26 angap-12 05:30am glucose-85 urean-20 creat-0.5 na-136 k-4.5 cl-101 hco3-24 angap-16 liver 05:52am alt-32 ast-25 ld(ldh)-207 alkphos-76 totbili-0.6 mri head 1. interval enlargement of ill-defined contrast enhancement in the anterior inferior left cerebellar hemisphere, most suggestive of progressing metastatic disease, which could be leptomeningeal and/or parenchymal. 2. stable small focus of cortical contrast enhancement, with a possible leptomeningeal component, in the parasagittal left parietal region, which could represent a stable metastasis, or a vascular malformation such as a cavernoma. csf atypical. rare single atypical cell, not sufficient for definitive characterization. csf immunophenotyping non-diagnostic study. clonality could not be assessed in this case due to insufficient numbers of b cells. cell marker analysis was attempted, but was non-diagnostic in this case due to insufficient numbers of cells. if clinically indicated, we recommend a repeat specimen be submitted to the flow cytometry laboratory. ct head there is also subtle edema in the left thalamus, which could represent acute ischemia. recommend evaluation with mri. ct head stable hemorrhage in the left external capsule and lateral putamen. cta abd/pelvis 1. no evidence of mesenteric ischemia. mild focal narrowing at the origin of the sma with associated post-stenotic dilatation unlikely of clinical significance with widely patent celiac axis and its major branches. 2. replaced left hepatic artery. 3. previously noted 2.5 x 1.3-cm right adrenal nodule can be characterized as an adrenal adenoma. 4. fibroid uterus. brief hospital course: hospital course 58yo f with pmh recurrent nsclc stage iiia s/p chemo/xrt c/b gastroparesis, a/w persistant n/v, hospital course c/b micu stay for htn emergency w iph, urinary retention, now w well-controlled bp, foley out without retention, no nausea/vomitting, discharged home. . active # htn: patient was admitted with recurrent htn episodes to sbp 220 in setting of vomiting and severe nausea, c/b intraparenchymal hemorrhage as discussed below. baseline htn was thought to nausea, vomitting, and urinary retention (found on imaging, believed to iatrogentic from anticholinergic medications). upon resolution of above issues, labile bp improved so that patient no longer required anti-htn medications. at time of discharge patient's bp was well controlled w sbp 102-140 over 24hrs. she underwent a workup for pheochromocytoma w negative urine metanephs. at time of discharge serum metas were pending. . # gastroparesis w n/v: patient with a chronic hx gastroparesis of uncertain etiology ( radiation v chemo v paraneoplastic v narcotics v tumor infiltration). during hospitalization, patient had improvement in nausea with narrowing of medications (it was thought that baseline nausea was being exacerbated by large amount of medications she was receiving). patient was advanced to a regular diet and tolerated it. at time of discharge she was continued on standing reglan and ativan with meals (all other anti-emetics discontinued). it was decided to defer a repeat upper gi series to the outpatient setting. . # urinary retention: during her hospitalization, patient was found to be retaining large amount of urine and had a foley placed. it was thought that the etiology most likely iatrogenic to anticholinergic action of medications (e.g. anti-emetics). her medications were narrowed, and she had her foley pulled w/o additional retention . # s/p ich: as mentioned above, on , in setting of htn urgency, patient found to have 1.8cm basal ganglia bleed on ct. neurosurg evaluated and felt that no surgical evacuation was needed. repeat ct 24hr later was stable. her aspirin was discontinued. . # nsclc: patient w history of nsclc w metastases. imaging demonstrated stable metastases, with suspected brain met, but lp showed only 1 atypical cell. patient was evaluated by neuro-onc (dr. who felt that lp and mri head should be repeated 1mo after discharge. further therapy was deferred to outpatient primary oncologist. . # thrush: patient found to have thrush during admission, thought to be inhaled steriod use. improved on nystatin and floconazole. at discharge, patient given script to finish 14d fluconazole (d1=). . inactive # asthma/copd: well controlled. patient was continued on home symbicort, albuterol, ipratropium, fluticasone propionate. . # depression: continued home celexa. . transitional 1. code status: patient remained full code. 2. pending: at time of discharge, plasma metanephrines were pending and will require follow-up 3. transition of care: patient was scheduled for follow-up with dr. . patient will need to be scheduled for a repeat mri and lp 4 weeks after discharge. medications on admission: lidocaine 5% patch 1 ptch td daily @ 2245 view alprazolam 0.5 mg po/ng alprazolam 0.5 mg po/ng qhs albuterol inhaler 2 puff ih q4h:prn sob hydrocodone-acetaminophen tab po q4h:prn pain trazodone 25 mg po/ng hs:prn insomnia simvastatin 20 mg po/ng daily metoprolol succinate xl 25 mg po daily ipratropium bromide mdi 2 puff ih qid folic acid 1 mg po/ng daily docusate sodium 100 mg po bid:prn constipation fluticasone propionate 110mcg 2 puff ih budesonide inh promethazine 12.5 mg iv q6h:prn nausea citalopram 20 mg po/ng daily plavix 75 mg qd aspirin 325 mg po/ng daily pantoprazole 40 mg iv q24h metoclopramide 10 mg po/iv tid morphine sulfate 1 mg iv q6h:prn pain lorazepam 0.5 mg iv q6h:prn nausea prochlorperazine 10 mg iv q6h:prn nausea ondansetron 4 mg iv q8h:prn nausea discharge medications: 1. lidocaine 5 %(700 mg/patch) adhesive patch, medicated sig: one (1) adhesive patch, medicated topical daily (daily). disp:*30 adhesive patch, medicated(s)* refills:*0* 2. metoclopramide 10 mg tablet sig: one (1) tablet po three times a day: with meals. disp:*90 tablet(s)* refills:*0* 3. lorazepam 0.5 mg tablet sig: one (1) tablet po tidac (3 times a day (before meals)). disp:*90 tablet(s)* refills:*0* 4. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 5. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. citalopram 20 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. budesonide-formoterol 80-4.5 mcg/actuation hfa aerosol inhaler sig: one (1) inhalation inhalation twice a day. disp:*2 inhalers* refills:*2* 8. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). disp:*2 inhalers* refills:*2* 9. fluconazole 100 mg tablet sig: one (1) tablet po q24h (every 24 hours) for 5 days. disp:*5 tablet(s)* refills:*0* 10. ipratropium bromide 17 mcg/actuation hfa aerosol inhaler sig: two (2) puff inhalation qid (4 times a day). disp:*2 inhalers* refills:*2* discharge disposition: home discharge diagnosis: primary non-small cell lung cancer secondary intraparenchymal hemorrhage gastroparesis discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: ms. , it was a pleasure taking care of you at . you were admitted for treatment of nausea, vomiting and high pressure. as a result of your high pressure, during your hospital stay you had a small bleed in your brain. the bleed was monitored by neurosurgery; it stopped, and the team decided that you did not need surgery. your pressure and nausea were treated with medications and they improved. during your hospital stay you were also found to be retaining urine. this was likely a side-effect of the many anti-nausea medications you were on. your medications were changed and you no longer retained urine. during this hospitalization many changes were made to your medications. to avoid confusion, we ask that you throw away all of your home medications, and fill the following prescriptions: 1) lidocaine patch - for pain 2) metoclopramide (reglan) - for nausea 3) lorazepam (ativan) - for nausea 4) pantoprazole (protonix) - for stomach ulcer 5) citalopram (celexa) 6) folic acid (folate) 7) budesonide-formoterol (symbicort) - for shortnes of breath 8) fluticasone - for shortness of breath 9) ipratropium - for shortness of breath 10) fluconazole - to treat a fungal infection in your mouth (take until ) please see below for your recommended follow-up appointments followup instructions: department: radiation oncology when: monday at 9:15 am with: address: .,, phone: department: hematology/oncology when: thursday at 9:30 am with: , md building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: thursday at 9:30 am with: , md building: sc clinical ctr campus: east best parking: garage md, procedure: spinal tap incision of lung parenteral infusion of concentrated nutritional substances other endoscopy of small intestine central venous catheter placement with guidance diagnoses: coronary atherosclerosis of native coronary artery tobacco use disorder unspecified essential hypertension hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status candidiasis of mouth intracerebral hemorrhage malignant neoplasm of upper lobe, bronchus or lung retention of urine, unspecified chronic obstructive asthma, unspecified secondary and unspecified malignant neoplasm of intrathoracic lymph nodes gastroparesis anemia in neoplastic disease parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use persistent vomiting 

Answer: The patient is high likely exposed to